Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.745 USD | -1.46% | +3.02% | -42.84% |
05-14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
479M | - | |||||
62.86B | - | |||||
41.38B | ||||||
40.38B | ||||||
27.64B | ||||||
26.46B |